Literature DB >> 18422381

Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis.

Mahyar Etminan1, Mohsen Sadatsafavi, Saeedreza Ganjizadeh Zavareh, Bahi Takkouche, J Mark FitzGerald.   

Abstract

BACKGROUND: Inhaled corticosteroids (ICS) are commonly prescribed medications for the management of asthma and chronic obstructive pulmonary disease. It is well established that long-term use of these drugs may lower bone mineral density. However, whether ICS increase the risk of fractures remains unknown. Recent studies that have attempted to explore this risk have had conflicting results. We sought to explore the risk of ICS and fractures among older adults by conducting a systematic review and meta-analysis of the literature.
METHODS: We systematically searched several databases, including MEDLINE, EMBASE and the Cochrane Library, to identify pertinent studies. Those studies that potentially met our inclusion criteria were identified by two reviewers. Relative risks (RRs) were pooled using the random effects model. We also explored dose-response by stratifying the analysis on high and low doses of ICS. Heterogeneity was assessed using the Q statistic and publication bias was assessed using the funnel plot.
RESULTS: Thirteen studies, including four randomized controlled trials, were included in the review. The pooled RRs for hip fractures and any fractures were 0.91 (95% CI 0.87, 0.96) and 1.02 (95% CI 0.96, 1.08), respectively. When we restricted the analysis to users of high-dose ICS, the pooled RRs for any fractures and hip fractures were 1.30 (95% CI 1.07, 1.58) and 1.32 (95% CI 0.90, 1.92), respectively. The funnel plot did not show evidence of publication bias.
CONCLUSION: We found no association between the use of ICS and fractures in older adults. A slight increase in risk was seen in those using high-dose ICS. The significance of this association should be investigated further.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422381     DOI: 10.2165/00002018-200831050-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  24 in total

Review 1.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.

Authors:  D Moher; D J Cook; S Eastwood; I Olkin; D Rennie; D F Stroup
Journal:  Lancet       Date:  1999-11-27       Impact factor: 79.321

2.  Inhaled or systemic corticosteroids and the risk of hospitalization for hip fracture among elderly women.

Authors:  Elaine Lau; Muhammad Mamdani; Karen Tu
Journal:  Am J Med       Date:  2003-02-01       Impact factor: 4.965

3.  Inhaled corticosteroids and hip fracture: a population-based case-control study.

Authors:  Richard B Hubbard; Chris J P Smith; Liam Smeeth; Tim W Harrison; Anne E Tattersfield
Journal:  Am J Respir Crit Care Med       Date:  2002-09-25       Impact factor: 21.405

4.  The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease.

Authors:  Catherine B Johannes; Gary A Schneider; Timothy J Dube; Tanya D Alfredson; Kourtney J Davis; Alexander M Walker
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

Review 5.  Epidemiology of chronic obstructive pulmonary disease (COPD).

Authors:  G Viegi; A Scognamiglio; S Baldacci; F Pistelli; L Carrozzi
Journal:  Respiration       Date:  2001       Impact factor: 3.580

Review 6.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

Review 7.  Effects of inhaled corticosteroids on bone.

Authors:  K J Mortimer; T W Harrison; A E Tattersfield
Journal:  Ann Allergy Asthma Immunol       Date:  2005-01       Impact factor: 6.347

Review 8.  Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.

Authors:  Shelley R Salpeter; Nicholas S Buckley
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

9.  Use of inhaled corticosteroids and the risk of fracture.

Authors:  Richard Hubbard; Anne Tattersfield; Chris Smith; Joe West; Liam Smeeth; Astrid Fletcher
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

10.  The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848].

Authors:  A E Fletcher; D A Jones; C J Bulpitt; A J Tulloch
Journal:  BMC Health Serv Res       Date:  2002-10-25       Impact factor: 2.655

View more
  14 in total

1.  Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment.

Authors:  M Gelardi; F Barbara; I Covelli; M A Damiani; F Plantone; A Notarnicola; B Moretti; N Quaranta; G Ciprandi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-01

2.  An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.

Authors:  Gwen S Skloot; Paula J Busse; Sidney S Braman; Elizabeth J Kovacs; Anne E Dixon; Carlos A Vaz Fragoso; Nicola Scichilone; Y S Prakash; Christina M Pabelick; Sameer K Mathur; Nicola A Hanania; Wendy C Moore; Peter G Gibson; Susan Zieman; Betina B Ragless
Journal:  Ann Am Thorac Soc       Date:  2016-11

Review 3.  Glucocorticoid-induced osteoporosis: who to treat with what agent?

Authors:  René Rizzoli; Emmanuel Biver
Journal:  Nat Rev Rheumatol       Date:  2014-11-11       Impact factor: 20.543

Review 4.  Asthma Over the Age of 65: All's Well That Ends Well.

Authors:  Alan P Baptist; Paula J Busse
Journal:  J Allergy Clin Immunol Pract       Date:  2018 May - Jun

Review 5.  An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.

Authors:  Sonal Singh; Yoon K Loke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

Review 6.  The Skeletal Effects of Inhaled Glucocorticoids.

Authors:  Stephanie A Sutter; Emily M Stein
Journal:  Curr Osteoporos Rep       Date:  2016-06       Impact factor: 5.096

Review 7.  Falls in patients with chronic obstructive pulmonary disease: a call for further research.

Authors:  Marc Roig; Janice J Eng; Jeremy D Road; W Darlene Reid
Journal:  Respir Med       Date:  2009-05-05       Impact factor: 3.415

Review 8.  Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.

Authors:  Kian Fan Chung; Gaetano Caramori; Ian M Adcock
Journal:  Eur J Clin Pharmacol       Date:  2009-06-26       Impact factor: 2.953

Review 9.  Interpretation and use of FRAX in clinical practice.

Authors:  J A Kanis; D Hans; C Cooper; S Baim; J P Bilezikian; N Binkley; J A Cauley; J E Compston; B Dawson-Hughes; G El-Hajj Fuleihan; H Johansson; W D Leslie; E M Lewiecki; M Luckey; A Oden; S E Papapoulos; C Poiana; R Rizzoli; D A Wahl; E V McCloskey
Journal:  Osteoporos Int       Date:  2011-07-21       Impact factor: 4.507

Review 10.  Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: an update of Brazilian Society of Rheumatology (2020).

Authors:  Rosa M R Pereira; Mariana O Perez; Ana Patrícia Paula; Caio Moreira; Charlles H M Castro; Cristiano A F Zerbini; Diogo S Domiciano; Elaine de Azevedo; Laura M C Mendonca; Marcia Midore Shinzato; Marco Antonio A da Rocha-Loures; Sebastião Radominski; Vera L Szejnfeld
Journal:  Arch Osteoporos       Date:  2021-03-01       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.